Business Context and Reporting Period
This Form 8-K filing by NSTS Bancorp, Inc. (NSTS) was submitted on February 7, 2025, regarding a corporate governance event. The registrant is incorporated in Delaware and its common stock trades on the NASDAQ Capital Market under the symbol "NSTS". The report addresses a temporary failure to meet Nasdaq listing standards following the unexpected death of a director.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and listing compliance rather than financial performance.
Material Changes
- Board Composition: The Board of Directors currently consists of six members following the passing of Mr. Thaddeus M. Bond, Jr. on January 3, 2025.
- Independence Status: Only three of the six current directors are classified as "independent directors" under Nasdaq Rule 5605(a)(2).
- Listing Compliance: The Company has temporarily fallen out of compliance with Nasdaq Rule 5605(b)(1), which requires a majority of the Board to be independent directors.
Outlook, Risks, and Management Commentary
Remediation Plan: Management intends to fill the vacancy on the Board of Directors with a person who meets the independence requirements of Nasdaq Rule 5605(b)(1) prior to the end of the cure period.
Compliance Deadline: The Company has until the earlier of its next annual stockholders' meeting or December 21, 2025, to regain compliance. If the next annual meeting is held before June 19, 2025, compliance must be evidenced no later than June 19, 2025.
Risks: The primary risk identified is the potential for delisting or failure to satisfy continued listing rules if the Board composition is not corrected within the specified timeframe.
Investor Verification Checklist
- Verify the date of the Company's next annual stockholders' meeting to determine the exact compliance deadline.
- Monitor future filings for the appointment of a new independent director to the Board.
- Confirm that the new appointee meets the specific independence criteria defined in Nasdaq Rule 5605(a)(2).
- Review the Company's proxy statement for the upcoming annual meeting to assess the final Board composition.